A prospective, single arm Physician Initiated Trial (PIT) to assess safety and efficacy of Biolimus A9-Eluting Stent (BES) - BioMatrix flex: All-Comers including complex case sub-group

Trial Profile

A prospective, single arm Physician Initiated Trial (PIT) to assess safety and efficacy of Biolimus A9-Eluting Stent (BES) - BioMatrix flex: All-Comers including complex case sub-group

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs Umirolimus (Primary)
  • Indications Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top